The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats

Psychopharmacology

Volumn 158, Issue 2, 2001, Pages 107-113

  Tsukamoto, Toshio ^a   Iyo, Masaomi ^b   Tani, Kunihiko ^a   Sekine, Yoshimoto ^a   Hashimoto, Kenji ^c   Ohashi, Yutaka ^a   Suzuki, Katsuaki ^a   Iwata, Yasuhide ^a   Mori, Norio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c WelFide Co   (Japan)

Author keywords

Calcineurin; FK506; Methamphetamine; Rat; Sensitization

Indexed keywords

CALCINEURIN INHIBITOR; DRUG VEHICLE; METHAMPHETAMINE; TACROLIMUS;

ANIMAL BEHAVIOR; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION; STEREOTYPY;

ANIMALS; BEHAVIOR, ANIMAL; CALCINEURIN; CENTRAL NERVOUS SYSTEM STIMULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; RATS; RATS, WISTAR; STEREOTYPED BEHAVIOR; TACROLIMUS;

EID: 0034752179     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130100870     Document Type: Article

References (42)

1. Effect of NO synthase inhibition on behavioral changes induced by a single administration of methamphetamine
2. Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine
3. Effect of NO synthesis inhibition on striatal dopamine release and stereotyped behavior induced by a single administration of methamphetamine
4. 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity
5. Effects of calcium channel entry blockers on cocaine and amphetamine-induced motor activities and toxicities
6. REM sleep deprivation decreases apomorphine-induced stimulation of locomotor activity but not stereotyped behavior in mice
7. Amphetamine use: Return of an old scourge in a consultation psychiatry setting
8. Cyclosporin-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats
9. D-Amphetamine-induced behavioral sensitization: Implication of a glutamatergic medial prefrontal cortex-ventral tegmental area innervation
10. 1 antagonist SCH23390 in comparison with neuroleptics
11. Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity
12. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: Relationship to calcineurin
13. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
14. Methamphetamines: Use and trafficking in the Tucson-Nogales area
15. Activation of NMDA receptors induced dephosphorylation of DARPP-32 in rat striatal slices
16. Calcineurin. Structure, function, and inhibition
17. Differentiation of the inhibitory effects of calcium antagonists on abnormal behaviors induced by methamphetamine or phencyclidine
18. SCH23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems
19. Enhanced dopamine release and phosphorylation of synapsin T and neuromodulin in striatal synaptosomes after repeated amphetamine
20. The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior
21. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram
22. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity
23. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine
24. DNQX blockade of amphetamine behavioral sensitization
25. Subchronic methamphetamine treatment enhances methamphetamine- or cocaine-induced dopamine efflux in vivo
26. Multiple receptors for dopamine
27. 2+-dependent phosphatase
28. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
29. 2 behavioral actions
30. Bidirectional regulation of DARPP-32 phosphorylation by dopamine
31. Behavioral sensitization and relative hyperresponsiveness of striatal and limbic dopaminergic neurons after repeated methamphetamine treatment
32. Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine
33. Pharmacology and physiology of stereotyped behavior
34. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
35. Acute exacerbation of paranoid psychotic state after long-term abstinence in patients with previous methamphetamine psychosis
36. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia
37. Dopamine receptors in brain and periphery
38. Human methamphetamine-related fatalities in Taiwan during 1991-1996
39. Neural actions of immunophilin ligands
40. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization
41. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area
42. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine